PRESS RELEASES

Found 258 Results
Page 2 of 26

Onxeo: report on the Extraordinary General Meeting of June 19, 2020


Paris (France), June 19, 2020 – 5.45 pm CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]

Tags:

06/19/2020



Onxeo offre 10,7% de son capital à Invus – Biotech Finances


(French only) Regards croisés : Interviews of Judith Greciet, CEO of Onxeo, and Mr Nicolas Trebouta, representing Financière de la […]

Tags:

06/15/2020


BFM Business Intégrale Bourse : Onxeo, Company of the Day


  Interview of Judith Greciet, CEO of Onxeo, following the entry into the capital of Invus, a long-term renowned investor […]

Tags: ,

06/10/2020


Onxeo announces a capital increase of €7.3 million by private placement to Invus and Financière de la Montagne, the Company’s historical shareholder


The funds raised will accelerate the development of Onxeo’s programs, and extend its cash runway into Q1 2022                 Paris […]

Tags:

06/09/2020


Onxeo announces that the Shareholders’ Meeting of May 29, 2020 has approved all ordinary resolutions


The Extraordinary General Meeting will be held on June 19, 2020 on the second call   Paris (France), May 29, […]

Tags:

05/29/2020


Onxeo Announces Approval of the REVocan Study By Regulatory Authorities


The REVocan study aims to evaluate the abrogation by AsiDNA™ of tumor resistance to a PARP inhibitor in relapsed ovarian […]

Tags:


Bryan Garnier & Co initiates the coverage of Onxeo with a “Buy” recommendation


Paris (France), May 27, 2020 – 8.45 am CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]

Tags:

05/27/2020


Onxeo to Present New Preclinical Data at AACR 2020 Confirming the Ability of AsiDNA™ to Reverse Cancer Resistance to PARPi


Paris (France), Mai 19, 2020 – 5.45 pm CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]

Tags:

05/19/2020


Onxeo’s Joint General Meeting in camera on May 29, 2020: availability of preparatory documents and live webcast login information


Paris (France), May 7, 2020 – 7:30 a.m. CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO – FR0010095596), (“Onxeo”, […]

Tags: ,

05/07/2020


Page 2 of 26